Pcn111 - Cost Estimate of Immune-Related Adverse Reactions Associated With Innovative Treatments of Metastatic Melanoma

Value in Health - United Kingdom
doi 10.1016/j.jval.2018.09.194
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Nivolumab in Resected and Unresectable Metastatic Melanoma: Characteristics of Immune-Related Adverse Events and Association With Outcomes

Clinical Cancer Research
Cancer ResearchOncology
2015English

Incidence and Cost Estimate of Treating Pediatric Adverse Drug Reactions in Lagos, Nigeria

Sao Paulo Medical Journal
Medicine
2011English

EL25Management of Immune-Related Adverse Events

Annals of Oncology
MedicineOncologyHematology
2018English

Association Between Myocarditis and Other Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitor Use: Analysis of the FDA Adverse Events Reporting System (FAERS)

Journal of Cardiac Failure
Cardiovascular MedicineCardiology
2019English

Mechanisms of Immune-Related Adverse Events Associated With Immune Checkpoint Blockade: Using Germline Genetics to Develop a Personalized Approach

Genome Medicine
Molecular MedicineGeneticsMolecular Biology
2019English

Pembrolizumab-Induced Sarcoid-Like Reactions During Treatment of Metastatic Melanoma

Radiology
Nuclear MedicineRadiologyImaging
2018English

Immune-Related Adverse Effects and Outcome of Patients With Cancer Treated With Immune Checkpoint Inhibitors

Anticancer Research
MedicineCancer ResearchOncology
2020English

Paraneoplastic Retinopathy Associated With Metastatic Cutaneous Melanoma of Unknown Primary Site

Eye
MedicineArtsSensory SystemsOphthalmologyHumanities
1997English

5) Management of Neurological Adverse Events Associated With Immune Checkpoint Inhibitors

Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine
Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy